Oncology & Cancer

T cell revival through PD-1: Clues for cancer immunotherapy

Cancer immunotherapy drugs that block the inhibitory PD-1 pathway have shown success in clinical trials and are now FDA-approved for melanoma, lung cancer and bladder cancer. Yet many patients' tumors do not respond to these ...

Diseases, Conditions, Syndromes

Tenofovir disoproxil fumarate can cut HBV transmission

(HealthDay)—Use of tenofovir disoproxil fumarate (TDF) during pregnancy can reduce the rate of mother-to-child transmission of hepatitis B virus (HBV), according to a study published in the June 16 issue of the New England ...

Medications

A legal approach to reducing drug spending

In a new analysis published in the May issue of Health Affairs, Aaron Kesselheim, MD, JD, MPH, associate professor of medicine and director of the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology ...

Immunology

'Key' to recognizing and immunizing herpes, common cold

Researchers at McMaster University have discovered a critical step in the immune system's recognition of DNA viruses. It's a key finding, they say, that could lead to vaccinations for herpes, the common cold or even cancer.

page 34 from 40